Gregory Pontone

Associate Professor

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gregory Pontone is an Associate Professor at Johns Hopkins Medicine in the United States. His research focuses on the psychiatric aspects of Parkinson's disease, including the impacts of dopamine therapy on cognition and mood, as well as the diagnosis and treatment of psychosis in this patient population. Recent publications address the necessity of specific drugs for psychiatric symptoms and the relationship between antidepressant use and impulse control disorders in Parkinson's disease.

Articles (21)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Kate Perepezko

University of Miami

UNITED STATES

View details

Ruth Schneider

University of Rochester Medical Center

UNITED STATES

View details

Alexander Pantelyat

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Bradley McDaniels

Assistant Professor, Rehabilitation Services Program Coordinator

University of North Texas

UNITED STATES

View details

Christopher Morrow

Johns Hopkins University School of Medicine

UNITED STATES

View details

Abhimanyu Mahajan

Assistant Professor

University of Cincinnati

UNITED STATES

View details

Cherie Marvel

Associate Professor

Johns Hopkins University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Pontone

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Investigating Dopamine Replacement–Associated Fluctuations in Cognition and Mood in Cognitively Unimpaired Parkinson's Disease

Do we need drugs for psychiatric symptoms specifically for Parkinson's disease?

On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis

Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease

Minor Phenomena in Parkinson’s Disease–Prevalence, Associations, and Risk of Developing Psychosis

Real or imagined: We need a new scale for psychosis in Parkinson's disease

The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease

Anxiety change after dopamine therapy in Parkinson disease is independent of motor improvement

A Prescription for Wellness in Early PD: Just What the Doctor Ordered

Reconceptualizing Catatonia as “Psychiatric Parkinsonism”

A Wellness Prescription for Parkinson's: Mid to Late-Stage Disease

Association of caregiver strain with the trajectory of quality of life in Parkinson's disease

‘Anxious fluctuators’ a subgroup of Parkinson's disease with high anxiety and problematic on-off fluctuations

Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease

Attentional dysfunction and the punding spectrum in Parkinson's disease.

Psychomotor processing and functional decline in Parkinson's disease predicted by the Purdue Pegboard test.

Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications.

Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

Invited Perspective on the "Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease".

A call for better depression treatment in people with Parkinson disease.

Lewy Body Degenerations as Neuropsychiatric Disorders.

Collaborators (7)

Kate Perepezko

Ruth Schneider

Alexander Pantelyat

Bradley McDaniels

Christopher Morrow

Abhimanyu Mahajan

Cherie Marvel

Make your next move.